+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Over the Counter (OTC) Analgesics Market 2020-2024 - Product Image

Global Over the Counter (OTC) Analgesics Market 2020-2024

  • ID: 5024952
  • Report
  • May 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • MORE
Over The Counter (OTC) Analgesics Market 2020-2024

The over the counter (OTC) analgesics market is poised to grow by $ 5.85 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period. The reports on over the counter (OTC) analgesics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of pain-related conditions and growing number of launches of OTC analgesics. In addition, increasing prevalence of pain-related conditions is anticipated to boost the growth of the market as well.

The over the counter (OTC) analgesics market analysis includes type segment and geographic landscapes.

The over the counter (OTC) analgesics market is segmented as below:

By Type
  • Internal OTC analgesics
  • external OTC analgesics
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies growing number of merger and acquisition (M&A) activities as one of the prime reasons driving the over the counter (OTC) analgesics market growth during the next few years.

The over the counter (OTC) analgesics market covers the following areas:
  • Over the counter (OTC) analgesics market sizing
  • Over the counter (OTC) analgesics market forecast
  • Over the counter (OTC) analgesics market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over the counter (OTC) analgesics market vendors that include Bayer AG, Cipla Inc., GlaxoSmithKline Plc, Johnson & Johnson, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, and Sun Pharmaceutical Industries Ltd.. Also, the over the counter (OTC) analgesics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

The market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Internal - Market size and forecast 2019-2024
  • External - Market size and forecast 2019-2024
  • Market opportunity by Type
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ billion)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Type - Market share 2019-2024 (%)
22: Comparison by Type
23: Internal - Market size and forecast 2019-2024 ($ billion)
24: Internal - Year-over-year growth 2019-2024 (%)
25: External - Market size and forecast 2019-2024 ($ billion)
26: External - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ billion)
32: North America - Year-over-year growth 2019-2024 (%)
33: Asia - Market size and forecast 2019-2024 ($ billion)
34: Asia - Year-over-year growth 2019-2024 (%)
35: Europe - Market size and forecast 2019-2024 ($ billion)
36: Europe - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ billion)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ billion)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Bayer AG - Overview
48: Bayer AG - Business segments
49: Bayer AG - Key offerings
50: Bayer AG - Key customers
51: Bayer AG - Segment focus
52: Cipla Inc. - Overview
53: Cipla Inc. - Business segments
54: Cipla Inc. - Key offerings
55: Cipla Inc. - Key customers
56: Cipla Inc. - Segment focus
57: GlaxoSmithKline Plc - Overview
58: GlaxoSmithKline Plc - Business segments
59: GlaxoSmithKline Plc - Key offerings
60: GlaxoSmithKline Plc - Key customers
61: GlaxoSmithKline Plc - Segment focus
62: Johnson & Johnson - Overview
63: Johnson & Johnson - Business segments
64: Johnson & Johnson - Key offerings
65: Johnson & Johnson - Key customers
66: Johnson & Johnson - Segment focus
67: Perrigo Co. Plc - Overview
68: Perrigo Co. Plc - Business segments
69: Perrigo Co. Plc - Key offerings
70: Perrigo Co. Plc - Key customers
71: Perrigo Co. Plc - Segment focus
72: Pfizer Inc. - Overview
73: Pfizer Inc. - Business segments
74: Pfizer Inc. - Key offerings
75: Pfizer Inc. - Key customers
76: Pfizer Inc. - Segment focus
77: Piramal Enterprises Ltd. - Overview
78: Piramal Enterprises Ltd. - Business segments
79: Piramal Enterprises Ltd. - Key offerings
80: Piramal Enterprises Ltd. - Key customers
81: Piramal Enterprises Ltd. - Segment focus
82: Reckitt Benckiser Group Plc - Overview
83: Reckitt Benckiser Group Plc - Business segments
84: Reckitt Benckiser Group Plc - Key offerings
85: Reckitt Benckiser Group Plc - Key customers
86: Reckitt Benckiser Group Plc - Segment focus
87: Sanofi - Overview
88: Sanofi - Business segments
89: Sanofi - Key offerings
90: Sanofi - Key customers
91: Sanofi - Segment focus
92: Sun Pharmaceutical Industries Ltd. - Overview
93: Sun Pharmaceutical Industries Ltd. - Business segments
94: Sun Pharmaceutical Industries Ltd. - Key offerings
95: Sun Pharmaceutical Industries Ltd. - Key customers
96: Sun Pharmaceutical Industries Ltd. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global over the counter (OTC) analgesics market: Bayer AG, Cipla Inc., GlaxoSmithKline Plc, Johnson & Johnson, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, and Sun Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing number of merger and acquisition (M&A) activities."

According to the report, one of the major drivers for this market is the increasing prevalence of pain-related conditions.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll